Guardian Pharmacy Services, Inc. Selling, General and Administrative Expense
Guardian Pharmacy Services, Inc. (GRDN) reported Selling, General and Administrative Expense of $59.40 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-08-06
- Guardian Pharmacy Services, Inc. selling, general and administrative expense for the quarter ending 2026-06-30 was $59.40M, a 6.90% increase year-over-year.
- Guardian Pharmacy Services, Inc. selling, general and administrative expense for the quarter ending 2026-03-31 was $58.63M, a 14.20% increase year-over-year.
- Guardian Pharmacy Services, Inc. selling, general and administrative expense for the quarter ending 2025-12-31 was $54.74M, a 8.72% increase year-over-year.
- Guardian Pharmacy Services, Inc. selling, general and administrative expense for the quarter ending 2025-09-30 was $58.37M, a 64.73% decline year-over-year.
- Guardian Pharmacy Services, Inc. selling, general and administrative expense for fiscal 2025 was $220.02M, a 28.40% decline from fiscal 2024.
- Guardian Pharmacy Services, Inc. selling, general and administrative expense for fiscal 2024 was $307.29M.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $59.40M 10-Q · filed 2026-08-06 | $118.03M 10-Q · filed 2026-08-06 | $172.77M derived: sum of 3 quarters · filed 2026-08-06 | $231.14M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $58.63M 10-Q · filed 2026-05-06 | $113.37M derived: sum of 2 quarters · filed 2026-05-06 | $171.74M derived: sum of 3 quarters · filed 2026-05-06 | $227.31M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $54.74M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | $113.11M derived: sum of 2 quarters · filed 2026-03-11 | $168.67M derived: sum of 3 quarters · filed 2026-08-06 | $220.02M 10-K · filed 2026-03-11 |
| 2025-09-30 | $58.37M 10-Q · filed 2025-11-10 | $113.93M derived: sum of 2 quarters · filed 2026-08-06 | $165.28M 10-Q · filed 2025-11-10 | $215.63M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $55.57M 10-Q · filed 2026-08-06 | $106.91M 10-Q · filed 2026-08-06 | $157.26M derived: sum of 3 quarters · filed 2026-08-06 | $322.75M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $51.34M 10-Q · filed 2026-05-06 | $101.69M derived: sum of 2 quarters · filed 2026-05-06 | $267.18M derived: sum of 3 quarters · filed 2026-05-06 | $311.47M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $50.35M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | $215.84M derived: sum of 2 quarters · filed 2026-03-11 | $260.12M derived: sum of 3 quarters · filed 2026-03-11 | $307.29M 10-K · filed 2026-03-11 |
| 2024-09-30 | $165.49M 10-Q · filed 2025-11-10 | $209.77M derived: sum of 2 quarters · filed 2025-11-10 | $256.94M 10-Q · filed 2025-11-10 | |
| 2024-06-30 | $44.28M 10-Q · filed 2025-08-11 | $91.45M 10-Q · filed 2025-08-11 | ||
| 2024-03-31 | $47.17M 10-Q · filed 2025-05-12 | |||
| 2023-09-30 | $58.52M 10-Q · filed 2024-11-12 | $128.31M 10-Q · filed 2024-11-12 |